Boris Labar

Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome

Gabriele Ihorst, U. Platzbecker, Ulrich Germing et al. · Haematologica · 2012 · 211 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA

S. Keating, Théo de Witte, Stefan Suciu et al. · British Journal of Haematology · 1998 · 91 citations · Full text

Medicine, Hematology, Immunology +17

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893).

Roel Willemze, Stefan Suciu, E Archimbaud et al. · PubMed · 1997 · 88 citations

Medicine, Oncology, Pharmacology +16

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

H. Ludwig, Zdeněk Adam, E Tóthová et al. · Haematologica · 2010 · 69 citations · Full text

Medicine, Geriatric Medicine, Oncology +12

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia

Roel Willemze, Nico van der Lely, H. Zwierzina et al. · Annals of Hematology · 1992 · 44 citations

Medicine, Hematology, Immunology +15